Propofol: an immunomodulating agent (Q36130653)

12 August 2017

1 reference

title

Propofol: an immunomodulating agent (English)

1 reference

12 August 2017

1 reference

Paul E Marik

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

issue

5 Pt 2

1 reference

12 August 2017

page(s)

28S-33S

1 reference

Effect of propofol on cerebrospinal fluid pressure and cerebral perfusion pressure in patients undergoing craniotomy

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Effect of propofol on cerebral blood flow and metabolism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol reduces neuronal transmission damage and attenuates the changes in calcium, potassium, and sodium during hyperthermic anoxia in the rat hippocampal slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol reduces infarct size and striatal dopamine accumulation following transient middle cerebral artery occlusion: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol anesthesia compared to awake reduces infarct size in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Neuroprotective effects of propofol following global cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Effects of graded suppression of the EEG with propofol on the neurological outcome following incomplete cerebral ischaemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol prevents delayed neuronal death following transient forebrain ischemia in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Management of head trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

The management of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Smooth muscle relaxant effects of propofol and ketamine in isolated guinea-pig trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

The effects of propofol and etomidate on airway contractility in chronically hypoxic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

The relaxant effect of propofol on guinea pig tracheal muscle is independent of airway epithelial function and beta-adrenoceptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol induces bronchodilation in mechanically ventilated chronic obstructive pulmonary disease (COPD) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol induces bronchodilation in a patient mechanically ventilated for status asthmaticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

The management of acute severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Effects of ketamine and propofol on the ratio of interleukin-6 to interleukin-10 during endotoxemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Effects of intravenous anesthetics on interleukin (IL)-6 and IL-10 production by lipopolysaccharide-stimulated mononuclear cells from healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Therapeutic effect of propofol in the treatment of endotoxin-induced shock in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Effects of propofol on endotoxin-induced acute lung injury in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol inhibits human neutrophil functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol reduces the migration of human leukocytes through endothelial cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Calcium administration increases the mortality of endotoxic shock in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Tumor necrosis factor-alpha converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Benefits and dangers of iron during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Iron, Infections, and Anemia of Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Iron-dependent activation of NF-kappaB in Kupffer cells: a priming mechanism for alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Signaling role of intracellular iron in NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Iron activates NF-kappaB in Kupffer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Production of nitric oxide by mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Compartmentalised inducible nitric-oxide synthase activity in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Sepsis is associated with reciprocal expressional modifications of constitutive nitric oxide synthase (NOS) in human skeletal muscle: down-regulation of NOS1 and up-regulation of NOS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol attenuates diaphragmatic dysfunction induced by septic peritonitis in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol reduces nitric oxide biosynthesis in lipopolysaccharide-activated macrophages by downregulating the expression of inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Specificity and properties of propofol as an antioxidant free radical scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

The antioxidant potential of propofol (2,6-diisopropylphenol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol is a peroxynitrite scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Tissue antioxidant capacity during anesthesia: propofol enhances in vivo red cell and tissue antioxidant capacity in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Antioxidant actions and early ultrastructural findings of thiopental and propofol in experimental spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Accumulation of intracellular ascorbate from dehydroascorbic acid by astrocytes is decreased after oxidative stress and restored by propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Sulfite supported lipid peroxidation in propofol emulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Role of lipid in sulfite-dependent propofol dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Soybean oil, stress response, and immune function: a clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

John M. Kinney International Awards. A summary of our work: effects of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Effect of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

n-3 versus n-6 polyunsaturated fatty acids in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Comparison of a lower-lipid propofol emulsion with the standard emulsion for sedation during monitored anesthesia care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

The pharmacodynamic effects of a lower-lipid emulsion of propofol: a comparison with the standard propofol emulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

Long-term sedation with propofol 60 mg ml(-1) vs. propofol 10 mg(-1) ml in critically ill, mechanically ventilated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.5_PART_2.28S

10.1592/PHCO.2005.25.5_PART_2.28S

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dvf3etbfkrahtkuzmppb7mqclu

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_dvf3etbfkrahtkuzmppb7mqclu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dvf3etbfkrahtkuzmppb7mqclu

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/dvf3etbfkrahtkuzmppb7mqclu

1 reference